These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7214226)

  • 61. [Effectiveness of intranasal immunization with Myxovirus influenzae neuraminidase in mice].
    Bottex C; Robert D; Fontanges R
    C R Acad Hebd Seances Acad Sci D; 1977 May; 284(19):1943-6. PubMed ID: 69501
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neuraminidase-inhibition assay for the identification of influenza A virus neuraminidase subtype or neuraminidase antibody specificity.
    Pedersen JC
    Methods Mol Biol; 2008; 436():67-75. PubMed ID: 18370042
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antigenic characteristics and genome composition of a naturally occurring recombinant influenza virus isolated from a pig in Japan.
    Nerome K; Sakamoto S; Yano N; Yamamoto T; Kobayashi S; Webster RG; Oya A
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2611-20. PubMed ID: 6198440
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
    Johansson BE; Kilbourne ED
    Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteers.
    Murphy BR; Markoff LJ; Chanock RM; Douglas RG; Betts RF; Cate TR; Couch RB
    Dev Biol Stand; 1977 Jun 1-3; 39():47-52. PubMed ID: 604132
    [No Abstract]   [Full Text] [Related]  

  • 66. Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).
    Gulati U; Hwang CC; Venkatramani L; Gulati S; Stray SJ; Lee JT; Laver WG; Bochkarev A; Zlotnick A; Air GM
    J Virol; 2002 Dec; 76(23):12274-80. PubMed ID: 12414967
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Determination of standard conditions for the influenza virus neuraminidase inhibition test].
    Mel'nikova SK; Gracheva EN; Alekseeva AK
    Vopr Virusol; 1976; (3):283-7. PubMed ID: 988673
    [No Abstract]   [Full Text] [Related]  

  • 68. [Reversion in the natural variability of influenza A virus].
    Iakhno MA; Isachenko VA; Molibog EV; Iamnikova SS; Vorkunova GK
    Vopr Virusol; 1978; (2):146-51. PubMed ID: 78585
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of syngeneic anti-idiotypic antibody on influenza virus neuraminidase antibody response.
    Mayer R; Ioannides C; Moran T; Johansson B; Bona C
    Viral Immunol; 1987; 1(2):121-34. PubMed ID: 3509674
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Primary structure of the full-length DNA copy of the neuraminidase gene in the avian influenza virus of the N7 antigenic subtype].
    Grinev AA; Petrov NA; Golovin SIa; Mamaev LV; Mikriukova TP
    Bioorg Khim; 1988 Mar; 14(3):416-8. PubMed ID: 3382443
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.
    Baker AT; Varghese JN; Laver WG; Air GM; Colman PM
    Proteins; 1987; 2(2):111-7. PubMed ID: 3447170
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Demonstration of antibodies to both hemagglutinin and neuraminidase antigens of H3N2 influenza A virus in domestic dogs.
    Kilbourne ED; Kehoe JM
    Intervirology; 1975-1976; 6(4-5):315-8. PubMed ID: 1235862
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Characteristics of different recombinants of the Philippine variety of influenza virus H3N2].
    Podcherniaeva RIa; Titenko AM; Grigor'ev VB; Iamnikova SS
    Vopr Virusol; 1986; 31(5):549-53. PubMed ID: 3798904
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase.
    Nuss JM; Whitaker PB; Air GM
    Proteins; 1993 Feb; 15(2):121-32. PubMed ID: 7680132
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Changes in the antigenicity of influenza virus neuraminidases due to various methods of preparation].
    Desselberger U
    Fortschr Med; 1978 Mar; 96(9):471-6. PubMed ID: 627393
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Serological foundation for the persisting circulation of influenza viruses A(HON1) and A(H2N2) among children].
    Ivanova NA; Grinbaum EB; Taros LIu; Luzianina TIa; Smorodintsev AA
    Vopr Virusol; 1982; 27(6):667-71. PubMed ID: 7157776
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans.
    Kilbourne ED
    J Infect Dis; 1976 Oct; 134(4):384-94. PubMed ID: 789791
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genetic relatedness of the neuramindase of influenza A strains Nav2, Nav3, and Nav6.
    Scholtissek C; Rott R; Lvov DK; Myasnikova IA
    Arch Virol; 1980; 65(3-4):325-8. PubMed ID: 7416973
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evidence for the contribution of the host species to the extent of antigenic variation of N1 influenza virus neuraminidase.
    Maywald F; Bosch FX; Orlich M; Rott R
    Med Microbiol Immunol; 1983; 172(1):1-11. PubMed ID: 6192318
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Solid-phase radioimmunoassay as a method for evaluating antigenic differences in type A influenza viruses.
    Schieble JH; Cottam D
    Infect Immun; 1977 Jan; 15(1):66-71. PubMed ID: 64458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.